Assessment of symptomatic rod fracture after posterior instrumented fusion for adult spinal deformity.

Published

Journal Article

BACKGROUND: Improved understanding of rod fracture (RF) in adult spinal deformity could be valuable for implant design, surgical planning, and patient counseling. OBJECTIVE: To evaluate symptomatic RF after posterior instrumented fusion for adult spinal deformity. METHODS: A multicenter, retrospective review of RF in adult spinal deformity was performed. Inclusion criteria were spinal deformity, age older than 18 years, and more than 5 levels posterior instrumented fusion. Rod failures were divided into early (≤12 months) and late (>12 months). RESULTS: Of 442 patients, 6.8% had symptomatic RF. RF rates were 8.6% for titanium alloy, 7.4% for stainless steel, and 2.7% for cobalt chromium. RF incidence after pedicle subtraction osteotomy (PSO) was 15.8%. Among patients with a PSO and RF, 89% had RF at or adjacent to the PSO. Mean time to early RF (63%) was 6.4 months (range, 2-12 months). Mean time to late RF (37%) was 31.8 months (range, 14-73 months). The majority of RFs after PSO (71%) were early (mean, 10 months). Among RF cases, mean sagittal vertical axis improved from preoperative (163 mm) to postoperative (76.9 mm) measures (P<.001); however, 16 had postoperative malalignment (sagittal vertical axis>50 mm; mean, 109 mm). CONCLUSION: Symptomatic RF occurred in 6.8% of adult spinal deformity cases and in 15.8% of PSO patients. The rate of RF was lower with cobalt chromium than with titanium alloy or stainless steel. Early failure was most common after PSO and favored the PSO site, suggesting that RF may be caused by stress at the PSO site. Postoperative sagittal malalignment may increase the risk of RF.

Full Text

Duke Authors

Cited Authors

  • Smith, JS; Shaffrey, CI; Ames, CP; Demakakos, J; Fu, K-MG; Keshavarzi, S; Li, CMY; Deviren, V; Schwab, FJ; Lafage, V; Bess, S; International Spine Study Group,

Published Date

  • October 2012

Published In

Volume / Issue

  • 71 / 4

Start / End Page

  • 862 - 867

PubMed ID

  • 22989960

Pubmed Central ID

  • 22989960

Electronic International Standard Serial Number (EISSN)

  • 1524-4040

Digital Object Identifier (DOI)

  • 10.1227/NEU.0b013e3182672aab

Language

  • eng

Conference Location

  • United States